加速康复外科理念在胃癌患者围手术期中的应用及新进展

doi:10.3760/cma.j.issn.1673-422X.2020.01.008

国际肿瘤学杂志 ›› 2020, Vol. 47 ›› Issue (1): 43-45.doi: 10.3760/cma.j.issn.1673-422X.2020.01.008

加速康复外科理念在胃癌患者围手术期中的应用及新进展

徐信, 陈博()

安徽医科大学第一附属医院普外科胃肠外科,合肥 230022

收稿日期:2019-11-22 修回日期:2019-12-08 出版日期:2020-01-08 发布日期:2020-03-22
通讯作者: 陈博 E-mail:chenbo831116@163.com
基金资助:
国家自然科学基金(81602425)

Application and new progress of enhanced recovery after surgery in perioperative period of gastric cancer patients

Xu Xin, Chen Bo()

Department of Gastrointestinal Surgery, First Affiliated Hospital of Anhui Medical University, Hefei 230022, China

Received:2019-11-22 Revised:2019-12-08 Online:2020-01-08 Published:2020-03-22
Contact: Chen Bo E-mail:chenbo831116@163.com
Supported by:
National Natural Science Foundation of China(81602425)

摘要/Abstract

摘要：

加速康复外科(ERAS)已被证实可以安全有效地应用于包括胃癌在内的多个外科领域,并在临床广泛开展,其应用范围覆盖了术前、术中和术后。目前在胃癌特殊人群中开展ERAS以及某些具体实施策略仍存有争议,胃癌ERAS的临床推广应用也面临着诸多问题。未来还需要更多高质量的循证医学证据和专业的临床实践团队来推动ERAS在胃癌领域的不断发展。

关键词: 胃肿瘤, 围手术期, 加速康复外科

Abstract:

Enhanced recovery after surgery (ERAS) has been proved to be safe and effective in several surgical fields, including gastric cancer, and has been widely applied in clinical practice, covering preoperative, intraoperative and postoperative applications. However, there are still controversies regarding the implementation of ERAS in specific populations of gastric cancer and some specific implementation strategies. At the same time, the clinical application of ERAS also faces many problems. In the future, more high-quality evidence and professional clinical practice teams will be needed to promote the development of ERAS in the gastric cancer field.

Key words: Stomach neoplasms, Perioperative period, Enhanced recovery after surgery

徐信, 陈博. 加速康复外科理念在胃癌患者围手术期中的应用及新进展[J]. 国际肿瘤学杂志, 2020, 47(1): 43-45.

Xu Xin, Chen Bo. Application and new progress of enhanced recovery after surgery in perioperative period of gastric cancer patients[J]. Journal of International Oncology, 2020, 47(1): 43-45.

参考文献 22

[1]	Ruiz-Tovar J, Garcia A, Ferrigni C , et al. Impact of implementation of an enhanced recovery after surgery (ERAS) program in laparoscopic Roux-en-Y gastric bypass: a prospective randomized clinical trial[J]. Surg Obes Relat Dis, 2019,15(2):228-235. DOI: 10.1016/j.soard.2018.11.002.
[2]	Batchelor TJP, Rasburn NJ, Abdelnour-Berchtold E , et al. Guidelines for enhanced recovery after lung surgery: recommendations of the enhanced recovery after surgery (ERAS ^®) society and the European society of thoracic surgeons (ESTS) [J]. Eur J Cardiothorac Surg, 2019,55(1):91-115. DOI: 10.1093/ejcts/ezy301.
[3]	Low DE, Allum W, De Manzoni G , et al. Guidelines for perioperative care in esophagectomy: enhanced recovery after surgery (ERAS ^®) society recommendations [J]. World J Surg, 2019,43(2):299-330. DOI: 10.1007/s00268-018-4786-4.
[4]	Desiderio J, Stewart CL, Sun V , et al. Enhanced recovery after surgery for gastric cancer patients improves clinical outcomes at a US cancer center[J]. J Gastric Cancer, 2018,18(3):230-241. DOI: 10.5230/jgc.2018.18.e24.
[5]	Mortensen K, Nilsson M, Slim K , et al. Consensus guidelines for enhanced recovery after gastrectomy: enhanced recovery after surgery (ERAS ^®) society recommendations [J]. Br J Surg, 2014,101(10):1209-1229. DOI: 10.1002/bjs.9582.
[6]	中国研究型医院学会机器人与腹腔镜外科专业委员会. 胃癌胃切除手术加速康复外科专家共识(2016版)[J]. 中华消化外科杂志, 2017,16(1):14-17. DOI: 10.3760/cma.j.issn.1673-9752.2017.01.003.
[7]	中华医学会外科学分会, 中华医学会麻醉学分会. 加速康复外科中国专家共识及路径管理指南(2018版)[J]. 中国实用外科杂志, 2018,38(1):1-20. DOI: 10.19538/j.cjps.issn1005-2208.2018.01.01.
[8]	Jeong O, Park YK, Jung MR , et al. Compliance with guidelines of enhanced recovery after surgery in elderly patients undergoing gastrectomy[J]. World J Surg, 2017,41(4):1040-1046. DOI: 10.1007/s00268-016-3845-y.
[9]	Zhao J, Hu J, Jiang Z , et al. Outcome of discharge within 72 hours of robotic gastrectomy using enhanced recovery after surgery programs[J]. J Laparoendosc Adv Surg Tech A, 2018,28(11):1279-1286. DOI: 10.1089/lap.2018.0051.
[10]	Zhao J, Wang G, Jiang ZW , et al. Patients administered neoadjuvant chemotherapy could be enrolled into an enhanced recovery after surgery program for locally advanced gastric cancer[J]. Chin Med J (Engl), 2018,131(4):413-419. DOI: 10.4103/0366-6999.225047.
[11]	Gao R, Yang H, Li Y , et al. Enhanced recovery after surgery in pediatric gastrointestinal surgery[J]. J Int Med Res, 2019,47(10):4815-4826. DOI: 10.1177/0300060519865350.
[12]	Wisely JC, Barclay KL . Effects of an enhanced recovery after surgery programme on emergency surgical patients[J]. ANZ J Surg, 2016,86(11):883-888. DOI: 10.1111/ans.13465.
[13]	Liu G, Jian F, Wang X , et al. Fast-track surgery protocol in elderly patients undergoing laparoscopic radical gastrectomy for gastric cancer: a randomized controlled trial[J]. Onco Targets Ther, 2016,9:3345-3351. DOI: 10.2147/OTT.S107443.
[14]	Bu J, Li N, Huang X , et al. Feasibility of fast-track surgery in elderly patients with gastric cancer[J]. J Gastrointest Surg, 2015,19(8):1391-1398. DOI: 10.1007/s11605-015-2839-7.
[15]	Li B, Liu HY, Guo SH , et al. Impact of early postoperative enteral nutrition on clinical outcomes in patients with gastric cancer[J]. Genet Mol Res, 2015,14(2):7136-7141. DOI: 10.4238/2015.June.29.7.
[16]	Shimizu N, Oki E, Tanizawa Y , et al. Effect of early oral feeding on length of hospital stay following gastrectomy for gastric cancer: a Japanese multicenter, randomized controlled trial[J]. Surg Today, 2018,48(9):865-874. DOI: 10.1007/s00595-018-1665-4.
[17]	Herbert G, Perry R, Andersen HK , et al. Early enteral nutrition within 24 hours of lower gastrointestinal surgery versus later commencement for length of hospital stay and postoperative complications[J]. Cochrane Database Syst Rev, 2019, 7: CD004080. DOI: 10.1002/14651858.CD004080.pub4.
[18]	Jeong O, Kim HG . Implementation of enhanced recovery after surgery (ERAS) program in perioperative management of gastric cancer surgery: a nationwide survey in Korea[J]. J Gastric Cancer, 2019,19(1):72-82. DOI: 10.5230/jgc.2019.19.e3.
[19]	Fumagalli Romario U, Weindelmayer J, Coratti A , et al. Enhanced recovery after surgery in gastric cancer: which are the main achievements from the Italian experience?[J]. Updates Surg, 2018,70(2):257-264. DOI: 10.1007/s13304-018-0522-8.
[20]	Elhassan A, Ahmed A, Awad H , et al. The evolution of surgical enhanced recovery pathways: a review[J]. Curr Pain Headache Rep, 2018,22(11):74. DOI: 10.1007/s11916-018-0727-z.
[21]	Francis NK, Walker T, Carter F , et al. Consensus on training and implementation of enhanced recovery after surgery: a delphi study[J]. World J Surg, 2018,42(7):1919-1928. DOI: 10.1007/s00268-017-4436-2.
[22]	Gianotti L, Fumagalli Romario U, De Pascale S , et al. Association between compliance to an enhanced recovery protocol and outcome after elective surgery for gastric cancer. results from a western population-based prospective multicenter study[J]. World J Surg, 2019,43(10):2490-2498. DOI: 10.1007/s00268-019-05068-x.

加速康复外科理念在胃癌患者围手术期中的应用及新进展

Application and new progress of enhanced recovery after surgery in perioperative period of gastric cancer patients

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 22

相关文章 15

编辑推荐

Metrics

本文评价

[1]	袁健, 黄燕华. Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[2]	杨琳, 路宁, 温华, 张明鑫, 朱琳. 炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[3]	解淑萍, 孙亚红, 汪超. 早期肿瘤标志物联合NLR、PLR预测胃癌免疫治疗疗效[J]. 国际肿瘤学杂志, 2024, 51(3): 157-165.
[4]	刘玉兰, 井海燕, 孙静, 宋伟, 沙丹. 胃癌免疫治疗疗效预测及预后标志物的研究进展[J]. 国际肿瘤学杂志, 2024, 51(3): 175-180.
[5]	邵慧芳, 王学红, 芦永福. CST1在胃癌进展中的作用机制及临床意义[J]. 国际肿瘤学杂志, 2023, 50(8): 489-492.
[6]	朱思雨, 王学红, 李文茜, 刘曙. 胃癌患者血清FABP1水平及其与幽门螺杆菌感染的关系[J]. 国际肿瘤学杂志, 2023, 50(6): 336-341.
[7]	杨娅, 王慧礼, 刘艳, 郭金凤, 王春霞, 吕敏, 山长平. GCSH基因在胃癌SNU-1细胞增殖和凋亡中的作用研究[J]. 国际肿瘤学杂志, 2023, 50(5): 257-262.
[8]	全祯豪, 徐飞鹏, 黄哲, 黄先进, 陈日红, 孙开裕, 胡旭, 林琳. 沉默lncRNA FTX通过miR-22-3p/NLRP3炎症体通路抑制胃癌细胞增殖[J]. 国际肿瘤学杂志, 2023, 50(4): 202-207.
[9]	姬薇, 关泉林, 陈雅蕊, 焦福智, 罗倩文. 血脂水平与胃癌的相关性[J]. 国际肿瘤学杂志, 2023, 50(3): 183-185.
[10]	范珊琳, 汪品秀, 孔飞, 周玉洁, 袁文臻. 胃癌新辅助化疗后肿瘤退缩分级预测因素的研究进展[J]. 国际肿瘤学杂志, 2023, 50(2): 112-116.
[11]	杨俊, 李荣, 曾建昌. 复方苦参注射液联合SOX方案治疗老年晚期胃癌的临床疗效[J]. 国际肿瘤学杂志, 2023, 50(2): 82-86.
[12]	邓莉莉, 段星宇, 李保中. HER2靶向药物及其联合治疗方案在胃及食管胃结合部腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2023, 50(12): 751-757.
[13]	李佳宜, 王跃, 尚兰兰, 徐兴, 赵岩. 人工智能技术在胃癌诊断与治疗中的实践与展望[J]. 国际肿瘤学杂志, 2023, 50(11): 677-682.
[14]	于晓鹏, 冯青青, 赵文飞, 赵文文, 魏红梅. 靶向治疗联合免疫检查点抑制剂在HER2阳性进展期胃癌中的应用[J]. 国际肿瘤学杂志, 2023, 50(10): 631-635.
[15]	李立立, 安有志, 王艳军. 替雷利珠单抗治疗MSI-H局部晚期胃癌患者1例[J]. 国际肿瘤学杂志, 2022, 49(7): 444-446.